Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68


Functional, cognitive and physical outcomes 3 years after minor lacunar or cortical ischaemic stroke.

McHutchison CA, Cvoro V, Makin S, Chappell FM, Shuler K, Wardlaw JM.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):436-443. doi: 10.1136/jnnp-2018-319134. Epub 2018 Dec 15.


Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.

Rothwell PM, Algra A, Chen Z, Diener HC, Norrving B, Mehta Z.

Lancet. 2016 Jul 23;388(10042):365-375. doi: 10.1016/S0140-6736(16)30468-8. Epub 2016 May 18.


Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.

Pendlebury ST, Rothwell PM; Oxford Vascular Study.

Lancet Neurol. 2019 Mar;18(3):248-258. doi: 10.1016/S1474-4422(18)30442-3. Epub 2019 Feb 12.


Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST).

Scutt P, Blackburn D, Krishnan K, Ballard C, Burns A, Ford GA, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Bath PM.

Trials. 2015 Nov 7;16:509. doi: 10.1186/s13063-015-1033-2.


Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke.

Winkel P, Bath PM, Gluud C, Lindschou J, van der Worp HB, Macleod MR, Szabo I, Durand-Zaleski I, Schwab S; EuroHYP-1 trial investigators.

Trials. 2017 Nov 29;18(1):573. doi: 10.1186/s13063-017-2302-z.


Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study.

van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A; LiLAC study group.

Lancet. 2005 Jun 18-24;365(9477):2098-104.


Cerebral microbleeds are not associated with long-term cognitive outcome in patients with transient ischemic attack or minor stroke.

Brundel M, Kwa VI, Bouvy WH, Algra A, Kappelle LJ, Biessels GJ; MICRO Study Group.

Cerebrovasc Dis. 2014;37(3):195-202. doi: 10.1159/000358119. Epub 2014 Feb 19.


Late functional improvement after lacunar stroke: a population-based study.

Ganesh A, Gutnikov SA, Rothwell PM; Oxford Vascular Study.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1301-1307. doi: 10.1136/jnnp-2018-318434. Epub 2018 Jul 21.


VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).

VITATOPS Trial Study Group, Hankey GJ, Algra A, Chen C, Wong MC, Cheung R, Wong L, Divjak I, Ferro J, de Freitas G, Gommans J, Groppa S, Hill M, Spence D, Lees K, Lisheng L, Navarro J, Ranawaka U, Ricci S, Schmidt R, Slivka A, Tan K, Tsiskaridze A, Uddin W, Vanhooren G, Xavier D, Armitage J, Hobbs M, Le M, Sudlow C, Wheatley K, Yi Q, Bulder M, Eikelboom JW, Hankey GJ, Ho WK, Jamrozik K, Klijn K, Koedam E, Langton P, Nijboer E, Tuch P, Pizzi J, Tang M, Antenucci M, Chew Y, Chinnery D, Cockayne C, Loh K, McMullin L, Smith F, Schmidt R, Chen C, Wong MC, de Freitas G, Hankey GJ, Loh K, Song S.

Int J Stroke. 2007 May;2(2):144-50. doi: 10.1111/j.1747-4949.2007.00111.x.


Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388).

TARDIS Trial Investigators, Krishnan K, Beridze M, Christensen H, Dineen R, Duley L, Heptinstall S, James M, Markus HS, Pocock S, Ranta A, Robinson T, Nikola N, Venables G, Bath P.

Int J Stroke. 2015 Oct;10(7):1159-65. doi: 10.1111/ijs.12538. Epub 2015 Jun 16.


Elevated platelet-derived growth factor AB/BB is associated with a lower risk of recurrent vascular events in stroke patients.

Narasimhalu K, Ma L, De Silva DA, Wong MC, Chang HM, Chen C.

Int J Stroke. 2015 Jan;10(1):85-9. doi: 10.1111/ijs.12358. Epub 2014 Sep 7.


Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group.

Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29. Erratum in: Lancet Neurol. 2008 Nov;7(11):985.


Cognitive screening improves the predictive value of stroke severity scores for functional outcome 3-6 months after mild stroke and transient ischaemic attack: an observational study.

Dong Y, Slavin MJ, Chan BP, Venketasubramanian N, Sharma VK, Crawford JD, Collinson SL, Sachdev P, Chen CL.

BMJ Open. 2013 Sep 3;3(9):e003105. doi: 10.1136/bmjopen-2013-003105.


Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke.

Böhm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener HC.

Eur Heart J. 2012 Nov;33(22):2804-12. doi: 10.1093/eurheartj/ehs250. Epub 2012 Aug 26.


Long-term outcome after ischaemic stroke/transient ischaemic attack.

Hankey GJ.

Cerebrovasc Dis. 2003;16 Suppl 1:14-9. Review.


Supplemental Content

Support Center